ALLOVIR INC (ALVR)
US0198181036 - Common Stock
ChartMill assigns a Buy % Consensus number of 44% to ALVR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.02. This target is 30.77% above the current price.
ALVR was analyzed by 10 analysts. The buy percentage consensus is at 44. So analysts seem to be rather negative about ALVR.
In the previous month the buy percentage consensus was at a similar level.
ALVR was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-26 | B of A Securities | Downgrade | Buy -> Underperform |
| 2023-12-22 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2023-12-22 | JP Morgan | Downgrade | Overweight -> Underweight |
| 2023-12-22 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-08-18 | B of A Securities | Initiate | Buy |
| 2023-08-07 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-04-26 | SVB Securities | Maintains | Outperform |
| 2023-01-27 | Morgan Stanley | Maintains | Overweight |
| 2023-01-23 | SVB Leerink | Maintains | Outperform |
| 2022-11-07 | SVB Leerink | Maintains | Outperform |
| 2022-09-09 | Morgan Stanley | Maintains | Overweight |
| 2022-07-28 | SVB Leerink | Maintains | Outperform |
| 2022-05-19 | Piper Sandler | Maintains | Overweight |
| 2022-02-10 | SVB Leerink | Maintains | Outperform |
| 2022-02-01 | BMO Capital | Initiate | Outperform |
| 2022-01-18 | Morgan Stanley | Maintains | Overweight |
| 2021-12-17 | SVB Leerink | Maintains | Outperform |
| 2021-11-08 | SVB Leerink | Maintains | Outperform |
| 2021-10-12 | Morgan Stanley | Maintains | Overweight |
| 2021-09-29 | Morgan Stanley | Maintains | Overweight |
| 2021-08-18 | Morgan Stanley | Maintains | Overweight |
| 2021-05-06 | SVB Leerink | Maintains | Outperform |
| 2021-04-19 | Morgan Stanley | Maintains | Overweight |